Equibles does not estimate personal net worth.
Get an email with a short summary when Inovio Pharmaceuticals, Inc. publishes a filing, an earnings call transcript or a press release.
Get INO alertsMike Sumner has spoken on 2 earnings calls across 1 company, most recently for Inovio Pharmaceuticals, Inc. on August 12, 2026. Inovio Pharmaceuticals, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Inovio Pharmaceuticals, Inc. includes Jacqueline E. Shea (CEO, COO and Board Member), Jacqueline Shea (CEO, COO and Board Member), Simon X. Benito (Chairman and Board Member) and 7 others.
“As Jackie noted, over the past several months, we have made considerable progress with INO 3107 on the regulatory front, as the FDA's review of the BLA continues to advance under the agency's Accelerated Approval Program.”
“As Jackie noted, since our BLA for INO 3107 was accepted for review under the Accelerated Approval Program program, in December of 2025, the FDA has been actively reviewing our submission.”
Source not stated
Biotechnology · Healthcare
